Our results confirm and extend to germline variants the fitness selection model proposed by Hoyos et al.9for somatic TP53 variants, postulating that cancer-associated variants are selected to optimally solve an evolutionary trade-off between oncogenic potential and neoantigen immunogenicity. The gene discussed is TP53; the disease is cancer.